Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

The goals of COPD therapy are to prevent and control symptoms, reduce the frequency and severity of exacerbations, and improve exercise tolerance. The triple combination therapy of inhaled corticosteroids (ICSs), long-acting beta(2) agonists (LABAs), and long-acting muscarinic antagonists (LAMAs) ha...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Singh, Dave, Corradi, Massimo, Spinola, Monica, Papi, Alberto, Usmani, Omar S, Scuri, Mario, Petruzzelli, Stefano, Vestbo, Jørgen
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5638574/
https://ncbi.nlm.nih.gov/pubmed/29062229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S146822
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky